StreetInsider.com News Articles

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Mon, 24 Aug 2026 08:15:00 -0400

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models.
Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging Roles of Pharmacists.
President and CEO Chaim Lebovits and executive team to conduct strategic regional partnership and healthcare investor meetings in Dubai.
DUPHAT to take place August 25 to 27, 2026, at the Dubai World Trade Centre.

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm

Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c

Mon, 17 Aug 2026 06:32:22 -0400

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q2 EPS of ($0.35), $0.06 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.

Form 10-Q BRAINSTORM CELL THERAPEU For: Jun 30

Fri, 14 Aug 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260814/26931931.html

Form 10-Q BRAINSTORM CELL THERAPEU For: Jun 30

Fri, 14 Aug 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260814/26931931.html

Form 8-K BRAINSTORM CELL THERAPEU For: Aug 14

Fri, 14 Aug 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260814/26931048.html

Form 8-K BRAINSTORM CELL THERAPEU For: Aug 14

Fri, 14 Aug 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260814/26931048.html

BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Fri, 14 Aug 2026 16:00:00 -0400

NEW YORK, Aug. 14, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate update.

BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Fri, 14 Aug 2026 16:00:00 -0400

BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Fri, 14 Aug 2026 16:00:00 -0400

BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Fri, 14 Aug 2026 16:00:00 -0400

BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Fri, 14 Aug 2026 16:00:00 -0400

BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Fri, 14 Aug 2026 16:00:00 -0400

BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Fri, 14 Aug 2026 16:00:00 -0400

BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Fri, 14 Aug 2026 16:00:00 -0400